Delivery Order SPE2DE24DA011-SPE2D626F03CJ
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $7,003.64 to Arthrex Inc. for a Proximal Tenodesis Implant System on December 9, 2025, with completion expected by December 12, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, reflecting Arthrex's competitive position as an established federal supplier. The award represents a task order under Arthrex's existing Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $35,314.35 delivery order to Arthrex Inc. on November 18, 2025, for a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment features an ultimate completion date of November 21, 2025, and will be performed at Arthrex's headquarters in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in federal orthopedic procurement. Arthrex Inc., a...
- Arthrex Inc. was awarded a delivery order valued at $1,694.84 for a Proximal Tenodesis Implant System on December 30, 2025, with an ultimate completion date of January 5, 2026. This fixed-price contract with economic price adjustment was issued without a set-aside designation and will be performed in Naples, Florida. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which supports orthopedic surgical needs across Department of Defense and Department of Veterans...
- The Department of Defense Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $5,284.18 on December 30, 2025, for an Implant System, SutureLoc product. This fixed-price delivery order with economic price adjustment is scheduled for completion by January 7, 2026, and will be performed at Arthrex's headquarters location in Naples, Florida. The contract was awarded without a set-aside designation, reflecting Arthrex's competitive position as a primary federal supplier of orthopedic...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,761.90 to Arthrex Inc. for a Proximal Tenodesis Implant System on December 15, 2025, with an ultimate completion date of December 18, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed at Arthrex's Naples, Florida facility. The award represents a task order issued under Arthrex's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $4,603.50 fixed-price delivery order to Arthrex Inc. for a Proximal Tenodesis Implant System, with performance scheduled for completion by December 24, 2025. The award, issued without set-aside designation on December 19, 2025, represents a task order under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) valued at $471M and effective through September 1, 2029. This master contract authorizes Arthrex to...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,932.74 to Arthrex Inc. for a Proximal Tenodesis Implant System, effective September 29, 2025, with an ultimate completion date of October 2, 2025. This fixed-price contract with economic price adjustment clauses was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contractor, headquartered in Naples,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $17,189.24 on August 26, 2025, for a Proximal Tenodesis Implant System. This fixed-price delivery order with economic price adjustment is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed in Naples, Florida, with an ultimate completion date of August 29, 2025. The contract was awarded without a set-aside designation,...
- The Department of Defense's Medical Supply Chain awarded Arthrex Inc. a $5,110.38 fixed-price delivery order for a Quadlink Implant System, 9mm, with an ultimate completion date of December 11, 2025. This delivery order was issued without a set-aside designation, reflecting Arthrex's competitive position as a leading supplier of minimally invasive orthopedic medical technologies to federal healthcare systems. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $28,109.95 for the Quadlink Implant System, 10MM on December 3, 2025, with an ultimate completion date of December 8, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation and is being funded through the Defense Logistics Agency's Medical Supply Chain, a component of the...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F03CJDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $4,556.26 to Arthrex Inc. on January 6, 2026, for a Proximal Tenodesis Implant System. The contract, classified as fixed price with economic price adjustment pricing, is scheduled for completion by January 15, 2026, and will be performed at Arthrex's headquarters in Naples, Florida. This delivery order was issued without set-aside designation, reflecting Arthrex's competitive position in federal orthopedic procurement. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, valued at $471.0 billion and effective through September 1, 2029. The master contract authorizes procurement of comprehensive orthopedic products and surgical technologies supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. As a leading manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, Arthrex serves as the prime contractor on this and numerous other delivery orders, supplying surgical implants, arthroscopic instruments, joint replacement technologies, and biologics directly to federal healthcare enterprises without subcontractor involvement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/5/26 |